Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone (Q44264708)

1 December 2017

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone (English)

1 reference

1 December 2017

0 references

Alan I Green

1

1 reference

1 December 2017

Ellen S Burgess

2

1 reference

1 December 2017

Ree Dawson

3

1 reference

1 December 2017

Suzannah V Zimmet

4

1 reference

1 December 2017

Rael D Strous

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

1 December 2017

Schizophrenia Research

1 reference

1 December 2017

60

1 reference

1 December 2017

1

1 reference

1 December 2017

81-85

1 reference

Decreased substance use in chronically psychotic patients treated with clozapine

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Characteristic hostility in schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Cocaine abuse among schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Patterns of substance abuse in schizophrenia: nature and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Relapse in schizophrenia: is there a relationship to substance abuse?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Cannabis and neuroleptic agents in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Influence of cannabis abuse on schizophrenic psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Effect of patient and family insight on compliance of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Marijuana use in schizophrenia: a clear hazard

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

Co-occurring disorders among mentally ill jail detainees: Implications for public policy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900231-1

7 January 2021

10.1016/S0920-9964(02)00231-1

Identifiers

DOI

1 reference

1 December 2017

1 reference